Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and in terms of Company's Code of Conduct for Prohibition of Insider Trading, Biogen Pharmachem Industries has informed that the trading window for dealing in the securities of the Company will remain closed from Thursday, 1st January, 2026 till 48 hours after the declaration of Unaudited Financial Results for the quarter ended on 31st December 2025. The date of proposed Board Meeting for considering the Unaudited financial results for the quarter ended on 31st December 2025 shall be informed in the due course.
The above information is a part of company’s filings submitted to BSE.
